Why use cannabis in old age?
Typical reasons are chronic pain (e.g. neuropathic/arthrosis), Trouble sleeping, Loss of appetite or spasticity. Meta-analyses and guidelines show: average benefit is rather small, but may be clinically relevant in selected patients – especially when standard options are insufficient or poorly tolerated. The BMJ panel (2021) therefore recommends schwacher a message trial administration of non-inhaled Cannabis medicines zusätzlich for routine therapy.
Current reviews (2023–2025) underline: Neuropathic pain is most likely to benefit; for other types of pain, the evidence is limited/heterogeneous.
Sleep: Improvements are possible, but on average small and not reliable – especially in older patients, often dependent on comorbidities (pain, anxiety).
Special risks for seniors
Older people often have multimorbidity and Polypharmacy – they react stronger on THC (sedation, confusion), which bell can promote. Observations/studies show increased risk of falling/walking For older cannabis users; caution is especially needed when starting/increasing use.
Cardiovascular: Regular consumption is associated with higher risk of heart attack/stroke/heart failure associated; risk increases with frequency of use. Be especially cautious in those with pre-existing cardiac conditions and critically examine inhalants.
Cognition/Neuropsychiatric: Older people are more susceptible to cognitive impairment, delirium, anxiety, especially at high THC doses. Data also show CUD risk (Cannabis Use Disorder) – hence screening & education.
Interactions (very important!)
Cannabinoids influence CYP enzymes (CYP2C19, CYP3A4, etc.). Documented interactions with, among others:
-
clobazam (Increase in active metabolites)
-
warfarin/DOACs (increased risk of bleeding → INR/Bleeding signs monitor)
-
Tacrolimus (Level rise)
-
multiple antiepileptics
Plan therapies → Interaction check & implement laboratory controls.
Application & dosage (“Start low, go slow”)
basic principles
-
Start low, langsam increase; first nachts test (sedation).
-
Defining a therapy goal (Pain ↓ x %, sleep +xh) and Time window (e.g. 4–8 weeks); continue only if beneficial.
-
Avoid smoking; non-inhaled Prefer forms, Evaporate possibly as a less harmful inhalation alternative (see below).
Example schemes (orientation, always medical!)
-
THC (non-inhalational): 1–2,5 mg in the evening; increase by 1–2,5 mg every 3–7 days until effect/side effect occurs.
-
CBD (non-inhalation): 5–10 mg 1–2 times/day; increase gradually (especially for anxiety/sleep, note interactions).
-
Combination: CBD during the day, low THC in the evening (e.g. 1–2,5 mg), titrate carefully.
-
Inhalation (vaporizer): 1–2 moves, Wait 15 minutes, repeat only if necessary; Temperature moderate (approx. 180–195 °C) for a gentle start.
Practical geriatric dosage recommendations (toolkit) emphasize the slow, step-by-step approach.
Note: Edibles work delayed (30–90 min, peak later) and longer; overdoses occur more frequently. Not suitable for first-time users.
Applications: What is suitable for older people?
-
Oral drops/sprays/capsules: slow onset of action, but longer lasting; preferred for basic pain, sleep. (BMJ recommendation refers explicitly to non-inhaled forms.)
-
Vaporization (vaporizer): no combustion, lower emissions compared to smoking; rapid onset of action – useful for breakthrough pain/nausea. However, be aware of cardiopulmonary risks. Smoking should be avoided.
Safety checklist for practice
-
Check pre-existing conditions: cardiac, psychiatric, cognitive, falls/gait unsteadiness.
-
Medication review: Anticoagulants, antiepileptics, immunosuppressants → interaction monitoring.
-
Therapy goal & termination criteria define (e.g. < 30% pain reduction after 8 weeks → discontinuation).
-
Fall prevention: Start sitting, test at night, use aids, change positions slowly.
-
ability to drive: Do not drive while under the influence/in case of dose escalation.
-
Follow up: initially weekly/fortnightly, later every 14–1 months.
Legal Quick Overview (Germany, 2025)
-
MedicalCannabis (flowers, extracts, THC-based finished medicinal products) is prescribable; since 2017, it has generally been reimbursable (subject to conditions). The CanG/MedCanG 2024/25 have restructured the legal framework (removing cannabis from the Narcotics Act; separate rules for medicinal use vs. recreational use/cultivation). Details/FAQs are available from the Federal Ministry of Health.
-
Important: This article replaces no individual medical advice.
Key messages in 30 seconds
-
Areas of application with partly moderate evidence: chronic pain (especially neuropathic), sleep disorders – benefit mostly small to moderate, varies greatly from individual to individual. A BMJ guideline recommends schwacher an temporary trial of non-inhaled Preparations in addition to standard therapy.
-
Older people are more vulnerable: more side effects (dizziness, confusion), Risk of falls, cardiovascular events – therefore dose with particular caution and monitor closely.
-
Avoid smoking. Evaporate can reduce emissions/pollutants compared to smoking (harm reduction), but should be assessed with caution in terms of cardio-/pulmonary risks.
-
Interactions: va CBD/THC with CYP substrates (e.g. clobazam, warfarin, tacrolimus, certain antiepileptic drugs) – plan monitoring (e.g. INR).
-
Germany (2025): Medical cannabis remains prescribable (flowers, extracts, THC-based finished medicines) – CanG/MedCanG have reformed the environment; Recreational CanG regulates possession/cultivation, not The therapy.
Frequently Asked Questions (FAQ)
Does cannabis reliably help with pain in old age?
For some – yes, especially for neuropathic painOn average, effects small; therefore as limited additional attempt to standard therapy.
Is vaping “healthy”?
Evaporation can increase emissions/pollutants compared to Smoking reduce (Harm Reduction), but no health guarantee, especially in cases of heart/lung diseases.
How do I start dosing?
"Start low, go slow– e.g., THC 1–2,5 mg in the evening, increase slowly; CBD 5–10 mg 1–2 times a day. Inhalation: 1–2 puffs, wait 15 minutes. Always supervise under medical supervision.
Which interactions are critical?
Clobazam, warfarin, tacrolimus, various antiepileptics (CYP-dependent). Laboratories/Mirrors monitor.
Does cannabis increase my risk of falls?
Can occur – especially at the start of therapy/when increasing the dose (dizziness, drop in blood pressure, sedation). Observe fall prevention measures.
Concluding Remarks
For seniors, cannabis can an option be - not the solution for everyone. The key is a individual, cautious Application with clear goals, close monitoring and honest benefit/risk assessment. Avoid smoking, Check interactions, Fall prevention take seriously – then a time-limited therapeutic trial be useful.
